Shay Shemesh
CIK: 0001896056
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVCT
Nuvectis Pharma, Inc.
Officer
Discretionary Trading P&L
Holdings
About Shemesh Shay
Shemesh Shay (SEC CIK 0001896056) files insider reports with the SEC as Chief Dev. & Ops. Officer of Nuvectis Pharma, Inc. (NVCT).
Signal8 holds 2 ownership filings by Shemesh Shay, all Form 4s, filed between Jan 3, 2025 and Jan 9, 2026. Those filings report 2 transactions, from Jan 2, 2025 to Jan 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shemesh Shay's filings is in FORT LEE, NJ.
Recent filings by Shemesh Shay
Other insiders filing for Nuvectis Pharma, Inc. (NVCT)
- Carson Michael J., Vice President, Finance
- Mosseri Marlio Charles, 10% Owner
- BENTSUR RON, Chairman & CEO
- Hoberman Kenneth, Director
- Oliviero James F III, Director
- Sanchez Juan, Director